Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain injury

BACKGROUND: The synthetic glucocorticoid dexamethasone (DEX) is commonly used to prevent chronic lung disease in prematurely born infants. Treatment regimens usually consist of high doses of DEX for several weeks, notably during a critical period of brain development. Therefore, there is some concer...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chang, Kan-Hsun, Yeh, Che-Ming, Yeh, Chia-Yu, Huang, Chiung-Chun, Hsu, Kuei-Sen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637314/
https://ncbi.nlm.nih.gov/pubmed/23594486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-6606-6-18
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller